Onco-Innovations and Redwood AI Secure Grant for SynoGraph Oncology Platform

Onco-Innovations Limited, alongside Redwood AI Corp., has received a grant from the Terry Fox Research Institute's Digital Health Innovation Fund to advance the AI-powered SynoGraph platform. The grant will cover up to 25% of an estimated $3.5 million budget. The project aims to integrate federated learning and causal AI to predict clinical outcomes using preclinical and real-world data while ensuring privacy and enhancing collaboration.

Redwood AI will aid with data integration and modelling to expand SynoGraph’s predictive capabilities. Contributions to the project include clinico-genomic data from Michael Smith Genome Sciences Centre and Quebec's CHU research center. This partnership aims to demonstrate how AI can drive therapeutic innovation by combining data sources and expertise.